CL
BSX icon

Choreo LLC’s Boston Scientific BSX Stock Holding History

Choreo LLC’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.97M Sell
47,300
-6,926
-13% -$554K 0.04% 303
2025
Q4 		$5.21M Sell
54,226
-3,896
-7% -$382K 0.07% 197
2025
Q3 		$5.67M Buy
58,122
+4,836
+9% +$501K 0.07% 183
2025
Q2 		$5.72M Buy
53,286
+3,211
+6% +$325K 0.08% 175
2025
Q1 		$5.05M Sell
50,075
-517
-1% -$52.1K 0.08% 179
2024
Q4 		$4.54M Buy
50,592
+19,187
+61% +$1.69M 0.07% 206
2024
Q3 		$2.64M Buy
31,405
+4,288
+16% +$338K 0.04% 290
2024
Q2 		$2.07M Buy
+27,117
New +$1.98M 0.03% 311

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Choreo LLC's BSX Position: Q1 2026 in Review

Choreo LLC reduced its Boston Scientific (BSX) stake by 13% in Q1 2026, selling an estimated $554K and leaving 47,300 shares worth $2.97M. The position accounts for 0.04% of the portfolio, ranked #303.

Choreo LLC first reported a position in BSX in Q2 2024 and has held it in 8 quarters since. The position peaked at $5.72M in Q2 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Choreo LLC held 47,300 shares of Boston Scientific worth $2.97M as of Q1 2026.
  • Choreo LLC sold 6,926 Boston Scientific shares in Q1 2026, an estimated $554K.
  • Boston Scientific made up 0.04% of Choreo LLC's portfolio in Q1 2026, its #303 holding.
  • Choreo LLC first reported a position in Boston Scientific in Q2 2024 and has held it in 8 quarters since.
  • Choreo LLC's Boston Scientific position peaked at $5.72M in Q2 2025.
  • 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Choreo LLC's 13F filing for Q1 2026, filed 13 May 2026.